Eris Lifesciences Limited

ERIS

Quarterly results

Revenue and net profit

₹ crore

Drag across a chart to read any period; every figure is listed under it. Tap the name of a metric for its year-on-year change.

  • Income
  • ₹ crore

    Sept 2026482

    Quarter₹ croreYoY
    Sept 2024429+4.6%
    Dec 2024400+23.2%
    Mar 2025405+18.6%
    Jun 2025579+26.7%
    Sept 2025651+51.7%
    Dec 2025315-21.1%
    Mar 2026277-31.5%
    Jun 2026444-23.3%
    Sept 2026482-25.9%
  • ₹ crore

    Sept 202619

    Quarter₹ crore
    Sept 202414
    Dec 20248
    Mar 202517
    Jun 202523
    Sept 202524
    Dec 202525
    Mar 202627
    Jun 202626
    Sept 202619
  • ₹ crore

    Sept 2026501

    Quarter₹ crore
    Sept 2024442
    Dec 2024408
    Mar 2025422
    Jun 2025601
    Sept 2025674
    Dec 2025340
    Mar 2026304
    Jun 2026470
    Sept 2026501
  • Cost structure
  • ₹ crore

    Sept 202682

    Quarter₹ crore
    Sept 202490
    Dec 202487
    Mar 202581
    Jun 202594
    Sept 202585
    Dec 202583
    Mar 202679
    Jun 202691
    Sept 202682
  • ₹ crore

    Sept 2026382

    Quarter₹ crore
    Sept 2024396
    Dec 2024401
    Mar 2025380
    Jun 2025445
    Sept 2025439
    Dec 2025322
    Mar 2026337
    Jun 2026406
    Sept 2026382
  • Exceptional items and tax
  • ₹ crore

    Sept 202684

    Quarter₹ crore
    Sept 202446
    Dec 20246
    Mar 202541
    Jun 2025156
    Sept 2025235
    Dec 20254
    Mar 2026-33
    Jun 202664
    Sept 202684
  • ₹ crore

    Sept 2026-46

    Quarter₹ crore
    Sept 202418
    Dec 20244
    Mar 202511
    Jun 202556
    Sept 202585
    Dec 20250.80
    Mar 2026-24
    Jun 202616
    Sept 2026-46
  • Profit
  • ₹ crore

    Sept 2026129

    Quarter₹ croreYoY
    Sept 202428-76.1%
    Dec 20242-94.4%
    Mar 202530-22.9%
    Jun 2025100+486.8%
    Sept 2025150+432.3%
    Dec 20253+73.6%
    Mar 2026-9-128.2%
    Jun 202648-51.7%
    Sept 2026129-13.7%
  • Per share
  • ₹ per share

    Sept 20269.32

    Quarter₹ per share
    Sept 20242.06
    Dec 20240.13
    Mar 20252.24
    Jun 20257.34
    Sept 202510.98
    Dec 20250.23
    Mar 2026-0.63
    Jun 20263.49
    Sept 20269.32
  • Leverage
  • Debt to equity

    times

    Sept 20260.01x

    Quartertimes
    Sept 20240.01x
    Dec 20240.01x
    Mar 20250.01x
    Jun 20250.01x
    Sept 20250.01x
    Dec 20250.01x
    Mar 20260.01x
    Jun 20260.01x
    Sept 20260.01x
₹ croreSept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026Sept 2026
Income
429400405579651315277444482
Revenue YoY+4.6%+23.2%+18.6%+26.7%+51.7%-21.1%-31.5%-23.3%-25.9%
14817232425272619
442408422601674340304470501
Cost structure
908781948583799182
396401380445439322337406382
Exceptional items and tax
466411562354-336484
1841156850.80-2416-46
Profit
282301001503-948129
Net profit YoY-76.1%-94.4%-22.9%+486.8%+432.3%+73.6%-128.2%-51.7%-13.7%
Per share
2.060.132.247.3410.980.23-0.633.499.32
Leverage
Debt to equity0.01x0.01x0.01x0.01x0.01x0.01x0.01x0.01x0.01x

Latest filed period ends Sept 2026. Figures are in ₹ crore except rows named with a %, which are percentages, and EPS, which is rupees per share. An asterisk on a YoY figure means the prior period was a loss, so the percentage is computed on its absolute value. Click an underlined row name for its year-on-year change, against the same period a year earlier — blank where that period was not filed, or, on rows other than revenue and net profit, where it is not one of the 9 shown. Every blank change says which of the two it is when you rest on the dash, so a gap in the oldest columns need not be read as no growth. Rows that are already a ratio carry no change: a move from 2.00% to 2.24% is 24 basis points, not a percentage.

VValue Huddle

Indian company filings, read properly. Ownership, results and pledges.

The data

  • 2,914 companies
  • Screener built 16 Nov 2026
  • No share prices, by design

Figures may contain errors of transcription or of the filing itself. Nothing here is investment advice, a recommendation, or a share price. Companies revise their filings; where we hold a revision, the revised figure is the one shown.